中华结核和呼吸杂志
中華結覈和呼吸雜誌
중화결핵화호흡잡지
Chinese Journal of Tuberculosis and Respiratory Diseases
2008年
2期
95-98
,共4页
傅瑜%初乃惠%苑松林%陈威%王巍%罗永艾%肖和平%朱莉贞
傅瑜%初迺惠%苑鬆林%陳威%王巍%囉永艾%肖和平%硃莉貞
부유%초내혜%원송림%진위%왕외%라영애%초화평%주리정
结核,肺%抗药性,多药%介入疗法
結覈,肺%抗藥性,多藥%介入療法
결핵,폐%항약성,다약%개입요법
Tuberculosis,pulmonary%Resistance,multi-drug%Interventional therapy
目的 评价介入疗法在耐多药结核病综合治疗中的作用.方法 2002年1至10月对沈阳市胸科医院等6家医院,心肺功能正常、伴肺部空洞的61例耐多药肺结核患者,在含帕司烟肼、利福喷汀、左旋氧氟沙星、乙胺丁醇、丙硫异烟胺、阿米卡星和克拉霉素化疗方案加母牛分枝杆菌免疫治疗的基础上,进行介入治疗,介入治疗后继续化疗至18个月.结果 介入治疗后3个月痰抗酸菌涂片同时结核分枝杆菌培养阴转率为50.8%(31/61),治疗18个月达83.6%(51/61).X线影像学结果显示,介入治疗后3个月病灶吸收显效率为50.8%(31/61),有效率为93.4%(57/61);治疗18个月显效率达78.7%(48/61),有效率为96.7%(59/61).疗程结束时显效率和有效率分别达78.7%(48/61),96.7%(59/61).经空洞闭合率介入后3个月为21.3%(13/61),治疗18个月达49.2%(30/61).治疗结束时发热、咯血、咳痰、乏力、呼吸困难等症状消失率为73.2%~94.4%.结论 介入疗法对耐多药肺结核具有加速痰细菌学阴转、病灶吸收和空洞闭合的作用,可促进症状改善,提高患者的生活质量.
目的 評價介入療法在耐多藥結覈病綜閤治療中的作用.方法 2002年1至10月對瀋暘市胸科醫院等6傢醫院,心肺功能正常、伴肺部空洞的61例耐多藥肺結覈患者,在含帕司煙肼、利福噴汀、左鏇氧氟沙星、乙胺丁醇、丙硫異煙胺、阿米卡星和剋拉黴素化療方案加母牛分枝桿菌免疫治療的基礎上,進行介入治療,介入治療後繼續化療至18箇月.結果 介入治療後3箇月痰抗痠菌塗片同時結覈分枝桿菌培養陰轉率為50.8%(31/61),治療18箇月達83.6%(51/61).X線影像學結果顯示,介入治療後3箇月病竈吸收顯效率為50.8%(31/61),有效率為93.4%(57/61);治療18箇月顯效率達78.7%(48/61),有效率為96.7%(59/61).療程結束時顯效率和有效率分彆達78.7%(48/61),96.7%(59/61).經空洞閉閤率介入後3箇月為21.3%(13/61),治療18箇月達49.2%(30/61).治療結束時髮熱、咯血、咳痰、乏力、呼吸睏難等癥狀消失率為73.2%~94.4%.結論 介入療法對耐多藥肺結覈具有加速痰細菌學陰轉、病竈吸收和空洞閉閤的作用,可促進癥狀改善,提高患者的生活質量.
목적 평개개입요법재내다약결핵병종합치료중적작용.방법 2002년1지10월대침양시흉과의원등6가의원,심폐공능정상、반폐부공동적61례내다약폐결핵환자,재함파사연정、리복분정、좌선양불사성、을알정순、병류이연알、아미잡성화극랍매소화료방안가모우분지간균면역치료적기출상,진행개입치료,개입치료후계속화료지18개월.결과 개입치료후3개월담항산균도편동시결핵분지간균배양음전솔위50.8%(31/61),치료18개월체83.6%(51/61).X선영상학결과현시,개입치료후3개월병조흡수현효솔위50.8%(31/61),유효솔위93.4%(57/61);치료18개월현효솔체78.7%(48/61),유효솔위96.7%(59/61).료정결속시현효솔화유효솔분별체78.7%(48/61),96.7%(59/61).경공동폐합솔개입후3개월위21.3%(13/61),치료18개월체49.2%(30/61).치료결속시발열、각혈、해담、핍력、호흡곤난등증상소실솔위73.2%~94.4%.결론 개입요법대내다약폐결핵구유가속담세균학음전、병조흡수화공동폐합적작용,가촉진증상개선,제고환자적생활질량.
Objective To evaluate the effect of interventional therapy with antituberculous drug instillation to the lesions in the treatment of multi-drug resistant pulmonary tuberculosis(MDR-PTB)on conventional therapy.Methods Sixty-one cases of MDR TB were included from January 2001 to October 2002 in five hospitals.Pasiniazide,rifapentine levofloxacin,ethambutol,ethionamide,amikacin and clarithromycin were used as the basic chemotherapy regimen.In addition,M.vaccac and interventional therapy were used,and chemotherapy was continued for a total of 18 months.Results The sputum negative conversion rate(including sputum smear and culture)was 50.8%(31/61)after 3 months of interventional therapy.The rate increased to 83.6%(51/61)after 18 months of therapy.Chest X-ray showed that,the foci were markedly absorbed in 50.8%(31/61),and the effective rate was 93.4%(57/61)after 3 months of therapy.The foci were markedly absorbed in 78.7%(48/61)after 18 months of treatment.The effective rate was 96.7%.The rate of cavity closure was 21.3%(13/61)after 3 months of interventional therapy and it increased to 49.2%(30/61)after 18 months of treatment.The rate of symptom disappearance was 73.2%-944%,including fever,hemoptysis and dyspnea.Conclusion For the treatment of MDR-TB,interventional therapy is effective in improving sputum negative conversion,lesion absorption and cavity closure.